Oragenics (OGEN) Research & Development (2010 - 2026)
Oragenics (OGEN) posted Research & Development of $1.18 million for Q2 2026, up 161.7% from $449,679 a year earlier and up 82.3% from the prior quarter.
Powered by 
Analysis
Oragenics (OGEN) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Oragenics was $3.42 million, up 2.6% year-over-year; for FY2025, it was $2.39 million, down 41.8% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -35.9% (FY2020 to FY2025).
- In prior years, Oragenics' Research & Development was $4.11 million in FY2024 (-73.4%), $15.49 million in FY2023 (+53.8%), $10.07 million in FY2022 (-4.9%) and $10.59 million in FY2021 (-52.1%).
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q4 2024.
- On a year-over-year basis, Research & Development increased in four of the last eight quarters, with growth averaging 3.4%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2023, with growth of 682.1%; the weakest was Q4 2024, with a decline of 84.9%.
- According to Business Quant data, Research & Development for the three prior quarters was $645,470 (Q1 2026), $670,543 (Q4 2025) and $930,894 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Oragenics | 2.12 Mn | 2.12 Mn | - | 1.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 645,470.00 |
| Dec 31, 2025 | 670,543.00 |
| Sep 30, 2025 | 930,894.00 |
| Jun 30, 2025 | 449,679.00 |
| Mar 31, 2025 | 341,542.00 |
| Dec 31, 2024 | 1.67 Mn |
| Sep 30, 2024 | 879,041.00 |
| Jun 30, 2024 | 906,779.00 |
| Mar 31, 2024 | 663,414.00 |
| Dec 31, 2023 | 11.04 Mn |
| Sep 30, 2023 | 769,350.00 |
| Jun 30, 2023 | 2.01 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 2.78 Mn |
| Jun 30, 2022 | 2.59 Mn |
| Mar 31, 2022 | 3.29 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | 3.55 Mn |
API Access
Oragenics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=OGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "OGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=OGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();